Immunization against viral respiratory disease

Healthy and at risk children are susceptible to the morbidity and mortality associated with viral-induced respiratory diseases, including respiratory syncytial virus (RSV) and influenza. The World Health Organization is attempting to develop and distribute effective vaccines to prevent/reduce key viral respiratory diseases. Effective vaccines are available for some viral respiratory pathogens (eg: influenza or virus), but not for most mucosal restricted respiratory viral pathogens. Research should continue into safe and effective vaccine for all childhood viral illnesses.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Seasonal influenza vaccine has proved effective in preventing laboratory-confirmed influenza among healthy adults (16–65 years of age) and children (6 years of age or older). The evidence of vaccine effectiveness is much more limited in relation to the prevention of complications such as pneumonia, hospitalisation and influenza-specific and overall mortality.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • viral-induced respiratory diseases
  • viral respiratory infections
  • viral respiratory pathogens
  • Various RSV vaccine formulations
  • Immunological disorders

Related Conference of Immunization against viral respiratory disease

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
October 01-03, 2018

Vaccine R&D: International Vaccine Congress

Dubai, UAE
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

Immunization against viral respiratory disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in